Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-059095
Filing Date
2015-08-12
Accepted
2015-08-12 16:15:45
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12131_110q.htm 10-Q 498058
2 EX-31.1 a15-12131_1ex31d1.htm EX-31.1 17236
3 EX-31.2 a15-12131_1ex31d2.htm EX-31.2 17483
4 EX-32.1 a15-12131_1ex32d1.htm EX-32.1 8673
5 EX-32.2 a15-12131_1ex32d2.htm EX-32.2 8722
  Complete submission text file 0001104659-15-059095.txt   2543184

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dprx-20150630.xml EX-101.INS 330196
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dprx-20150630.xsd EX-101.SCH 30146
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dprx-20150630_cal.xml EX-101.CAL 20473
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dprx-20150630_def.xml EX-101.DEF 102315
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dprx-20150630_lab.xml EX-101.LAB 273896
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dprx-20150630_pre.xml EX-101.PRE 198688
Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 151047188
SIC: 2834 Pharmaceutical Preparations